Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Donata Linkevičiūtė-Ulinskienė

Biographic Data

ID7867987
NAMEDonata Linkevičiūtė-Ulinskienė
GIVEN NAMESDonata
FAMILY NAMELinkevičiūtė-Ulinskienė
SIGNATURELINKEVIČIŪTĖ-ULINSKIENĖ D
AFFILIATIONSVilnius University
ORCID0000-0003-1168-2003
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2020
H-INDEX0
  • Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania

    Open Access•Donata Linkevičiūtė-Ulinskienė, Augustė Kačėnienė et al.•ARTICLE•International Journal of…•2020

    This retrospective cohort study aimed to analyze overall and cause-specific mortality risk in people with type 2 diabetes mellitus (T2DM) in Lithuania. Information on the diagnosis of T2DM and glucose-lowering medication was obtained from the National Health Insurance Fund database, causes of death-from death certificates. Sex, age, and calendar period-standardized mortality ratios (SMRs) were calculated. In addition, 89,512 patients were followe…

  • Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival

    Open Access•Audrius Dulskas, Aušvydas Patašius et al.•ARTICLE•International Journal of…•2020

    Our study showed that metformin might have a survival benefit for pancreatic cancer patients, suggesting a potentially available option for the treatment

  • A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer

    Open Access•Edvardas Danila, Donata Linkevičiūtė-Ulinskienė et al.•ARTICLE•International Journal of…•2020

    We evaluated the effect of antihyperglycemic therapy on the survival of patients with lung cancer (LC). The analysis included patients with LC and concomitant type 2 diabetes. 15,929 patients were classified into five groups: metformin users, insulin users, metformin and insulin users, sulphonylurea users and non-diabetic group. A multivariate analysis showed that exposure to either metformin or to insulin was associated with a lower risk of LC-s…

  • Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes

    Open Access•Donata Linkevičiūtė-Ulinskienė, Aušvydas Patašius et al.•ARTICLE•International Journal of…•2019

    A retrospective cohort design was used with the objective to evaluate cancer risk among people with type 2 diabetes mellitus (T2DM) in Lithuania. The cohort was established by identifying all patients with the first diagnosis of T2DM in the National Health Insurance Fund database during 2000-2012. Cancer cases were identified by record linkage with the Lithuanian Cancer Registry. Standardized incidence ratios (SIRs) were calculated. Of the 127,29…

No prominent works on this page.

  • Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes

    Open Access•Donata Linkevičiūtė-Ulinskienė, Aušvydas Patašius et al.•ARTICLE•International Journal of…•2019

    A retrospective cohort design was used with the objective to evaluate cancer risk among people with type 2 diabetes mellitus (T2DM) in Lithuania. The cohort was established by identifying all patients with the first diagnosis of T2DM in the National Health Insurance Fund database during 2000-2012. Cancer cases were identified by record linkage with the Lithuanian Cancer Registry. Standardized incidence ratios (SIRs) were calculated. Of the 127,29…

  • Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania

    Open Access•Donata Linkevičiūtė-Ulinskienė, Augustė Kačėnienė et al.•ARTICLE•International Journal of…•2020

    This retrospective cohort study aimed to analyze overall and cause-specific mortality risk in people with type 2 diabetes mellitus (T2DM) in Lithuania. Information on the diagnosis of T2DM and glucose-lowering medication was obtained from the National Health Insurance Fund database, causes of death-from death certificates. Sex, age, and calendar period-standardized mortality ratios (SMRs) were calculated. In addition, 89,512 patients were followe…

  • Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival

    Open Access•Audrius Dulskas, Aušvydas Patašius et al.•ARTICLE•International Journal of…•2020

    Our study showed that metformin might have a survival benefit for pancreatic cancer patients, suggesting a potentially available option for the treatment

  • A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer

    Open Access•Edvardas Danila, Donata Linkevičiūtė-Ulinskienė et al.•ARTICLE•International Journal of…•2020

    We evaluated the effect of antihyperglycemic therapy on the survival of patients with lung cancer (LC). The analysis included patients with LC and concomitant type 2 diabetes. 15,929 patients were classified into five groups: metformin users, insulin users, metformin and insulin users, sulphonylurea users and non-diabetic group. A multivariate analysis showed that exposure to either metformin or to insulin was associated with a lower risk of LC-s…

Cohort (4 works) · Cohort study (4 works) · Internal Medicine (4 works) · Medicine (4 works) · Metabolism, Diabetes, and Cancer (4 works) · Diabetes mellitus (3 works) · Endocrinology (3 works) · Pancreatic and Hepatic Oncology Research (3 works) · Cancer (2 works) · Confidence interval (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae